Increased cardio-ankle vascular index in hyperlipidemic patients without diabetes or hypertension

Journal of Atherosclerosis and Thrombosis

Volumn 22, Issue 3, 2015, Pages 272-283

  Dobsak, Petr ^a,b   Soska, Vladimir ^a,b   Sochor, Ondrej ^b,c   Jarkovsky, Jiri ^a   Novakova, Marie ^a   Homolka, Martin ^b,d   Soucek, Miroslav ^a,b   Palanova, Petra ^a   Lopez Jimenez, Francisco ^c   Shirai, Kohji ^e  

^a MASARYK UNIVERSITY   (Czech Republic)

^b ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

^c MAYO CLINIC   (United States)

^d MENDEL UNIVERSITY IN BRNO   (Czech Republic)

^e TOHO UNIVERSITY SAKURA MEDICAL CENTER   (Japan)

Author keywords

Cardio ankle vascular index; Combined hyperlipidemia; Hypercholesterolemia

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTERIAL STIFFNESS; ARTICLE; BLOOD ANALYSIS; BLOOD PRESSURE MONITORING; BLOOD VESSEL PARAMETERS; CARDIO ANKLE VASCULAR INDEX; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; ANKLE; COMPLICATION; PATHOPHYSIOLOGY; VASCULARIZATION; YOUNG ADULT;

ADULT; ANKLE; DIABETES COMPLICATIONS; FEMALE; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; MALE; YOUNG ADULT;

EID: 84925354490     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.24851     Document Type: Article

References (63)

1. Cooney MT, Dudina A, De Bacquer D, Wilhelmsen L, Sans S, Menotti A, De Backer G, Jousilahti P, Keil U, Thomsen T, Whincup P, Graham IM, investigators S: HDL cholesterol protects against cardiovascular disease in both genders, at all ages and at all levels of risk. Atherosclerosis, 2009; 206: 611-616
2. Sarwar N, Danesh J, Eiriksdottir G, Sigurdsson G, Wareham N, Bingham S, Boekholdt SM, Khaw KT, Gudnason V: Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies. Circulation, 2007; 115: 450- 458
3. Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, Simes R, Collaborators CTTC: Efficacy and safety of cholesterol- lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet, 2005; 366: 1267-1278
4. van Popele NM, Grobbee DE, Bots ML, Asmar R, Topouchian J, Reneman RS, Hoeks AP, van der Kuip DA, Hofman A, Witteman JC: Association between arterial stiffness and atherosclerosis: the Rotterdam Study. Stroke, 2001; 32: 454-460
5. Munakata M, Sakuraba J, Tayama J, Furuta T, Yusa A, Nunokawa T, Yoshinaga K, Toyota T: Higher brachialankle pulse wave velocity is associated with more advanced carotid atherosclerosis in end-stage renal disease. Hypertens Res, 2005; 28: 9-14
6. Tomiyama H, Koji Y, Yambe M, Shiina K, Motobe K, Yamada J, Shido N, Tanaka N, Chikamori T, Yamashina A: Brachial -- ankle pulse wave velocity is a simple and independent predictor of prognosis in patients with acute coronary syndrome. Circ J, 2005; 69: 815-822
7. Imanishi R, Seto S, Toda G, Yoshida M, Ohtsuru A, Koide Y, Baba T, Yano K: High brachial-ankle pulse wave velocity is an independent predictor of the presence of coronary artery disease in men. Hypertens Res, 2004; 27: 71-78
8. Yambe T, Yoshizawa M, Saijo Y, Yamaguchi T, Shibata M, Konno S, Nitta S, Kuwayama T: Brachio-ankle pulse wave velocity and cardio-ankle vascular index (CAVI). Biomed Pharmacother, 2004; 58 Suppl 1: S95-98
9. Izuhara M, Shioji K, Kadota S, Baba O, Takeuchi Y, Uegaito T, Mutsuo S, Matsuda M: Relationship of cardioankle vascular index (CAVI) to carotid and coronary arteriosclerosis. Circ J, 2008; 72: 1762-1767
10. Mitchell GF, Hwang SJ, Vasan RS, Larson MG, Pencina MJ, Hamburg NM, Vita JA, Levy D, Benjamin EJ: Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation, 2010; 121: 505-511
11. Shirai K, Utino J, Otsuka K, Takata M: A novel blood pressure-independent arterial wall stiffness parameter; cardio- ankle vascular index (CAVI). J Atheroscler Thromb, 2006; 13: 101-107
12. Shirai K, Utino J, Saiki A, Endo K, Ohira M, Nagayama D, Tatsuno I, Shimizu K, Takahashi M, Takahara A: Evaluation of blood pressure control using a new arterial stiffness parameter, cardio-ankle vascular index (CAVI). Curr Hypertens Rev, 2013; 9: 66-75
13. Kubozono T, Miyata M, Ueyama K, Nagaki A, Otsuji Y, Kusano K, Kubozono O, Tei C: Clinical significance and reproducibility of new arterial distensibility index. Circ J, 2007; 71: 89-94
14. Kotani K: Cardio-Ankle Vascular Index (CAVI) and its Potential Clinical Implications for Cardiovascular Disease. 2013; 2: 108
15. Sun CK: Cardio-ankle vascular index (CAVI) as an indicator of arterial stiffness. Integr Blood Press Control, 2013; 6: 27-38
16. Shirai K, Hiruta N, Song M, Kurosu T, Suzuki J, Tomaru T, Miyashita Y, Saiki A, Takahashi M, Suzuki K, Takata M: Cardio-ankle vascular index (CAVI) as a novel indicator of arterial stiffness: theory, evidence and perspectives. J Atheroscler Thromb, 2011; 18: 924-938
17. Miyoshi T, Doi M, Hirohata S, Sakane K, Kamikawa S, Kitawaki T, Kaji Y, Kusano KF, Ninomiya Y, Kusachi S: Cardio-ankle vascular index is independently associated with the severity of coronary atherosclerosis and left ventricular function in patients with ischemic heart disease. J Atheroscler Thromb, 2010; 17: 249-258
18. Kanamoto M, Matsumoto N, Shiga T, Kunimoto F, Saito S: Relationship between coronary artery stenosis and cardio- ankle vascular index (CAVI) in patients undergoing cardiovascular surgery. J Cardiovasc Dis Res, 2013; 4: 15-19
19. Yingchoncharoen T, Limpijankit T, Jongjirasiri S, Laothamatas J, Yamwong S, Sritara P: Arterial stiffness contributes to coronary artery disease risk prediction beyond the traditional risk score (RAMA-EGAT score). Heart Asia, 2012; 4: 77-82
20. Kim KJ, Lee BW, Kim HM, Shin JY, Kang ES, Cha BS, Lee EJ, Lim SK, Lee HC: Associations between cardioankle vascular index and microvascular complications in type 2 diabetes mellitus patients. J Atheroscler Thromb, 2011; 18: 328-336
21. Park JB, Park HE, Choi SY, Kim MK, Oh BH: Relation between cardio-ankle vascular index and coronary artery calcification or stenosis in asymptomatic subjects. J Atheroscler Thromb, 2013; 20: 557-567
22. Cheng HM, Chuang SY, Sung SH, Yu WC, Pearson A, Lakatta EG, Pan WH, Chen CH: Derivation and validation of diagnostic thresholds for central blood pressure measurements based on long-term cardiovascular risks. J Am Coll Cardiol, 2013; 62: 1780-1787
23. Kato A, Takita T, Furuhashi M, Maruyama Y, Miyajima H, Kumagai H: Brachial-ankle pulse wave velocity and the cardio-ankle vascular index as a predictor of cardiovascular outcomes in patients on regular hemodialysis. Ther Apher Dial, 2012; 16: 232-241
24. Satoh N, Shimatsu A, Kato Y, Araki R, Koyama K, Okajima T, Tanabe M, Ooishi M, Kotani K, Ogawa Y: Evaluation of the cardio-ankle vascular index, a new indicator of arterial stiffness independent of blood pressure, in obesity and metabolic syndrome. Hypertens Res, 2008; 31: 1921-1930
25. Noike H, Nakamura K, Sugiyama Y, Iizuka T, Shimizu K, Takahashi M, Hirano K, Suzuki M, Mikamo H, Nakagami T, Shirai K: Changes in cardio-ankle vascular index in smoking cessation. J Atheroscler Thromb, 2010; 17: 517-525
26. Ibata J, Sasaki H, Kakimoto T, Matsuno S, Nakatani M, Kobayashi M, Tatsumi K, Nakano Y, Wakasaki H, Furuta H, Nishi M, Nanjo K: Cardio-ankle vascular index measures arterial wall stiffness independent of blood pressure. Diabetes Res Clin Pract, 2008; 80: 265-270
27. Tian G, Wei W, Zhang W, Zhang L, You H, Liu W, Sun Z, Wang X, Wu X: Increasing age associated with elevated cardio-ankle vascular index scores in patients with type 2 diabetes mellitus. J Int Med Res, 2013; 41: 435-444
28. Choi SY, Oh BH, Park JB, Choi DJ, Rhee MY, Park S: Age-Associated Increase in Arterial Stiffness Measured According to the Cardio-Ankle Vascular Index without Blood Pressure Changes in Healthy Adults. J Atheroscler Thromb, 2013
29. Hiroi N, Mogami K, Ishimori H, Ono K, Higa M: Analysis for atherosclerosis in type 2 diabetic patients using a novel pulse wave velocity measurement - cardio-ankle vascular index. Diabetologia, 2005; 48: A263-A264
30. Soska V, Dobsak P, Dusek L, Shirai K, Jarkovsky J, Novakova M, Brhel P, Stastna J, Fajkusova L, Freiberger T, Yambe T: Cardio-ankle vascular index in heterozygous familial hypercholesterolemia. J Atheroscler Thromb, 2012; 19: 453-461
31. Catapano AL, Reiner Z, De Backer G, Graham I, Taskinen MR, Wiklund O, Agewall S, Alegria E, Chapman M, Durrington P, Erdine S, Halcox J, Hobbs R, Kjekshus J, Filardi PP, Riccardi G, Storey RF, Wood D, (ESC) ESoC, (EAS) EAS: ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Atherosclerosis, 2011; 217: 3-46
32. Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, Albus C, Benlian P, Boysen G, Cifkova R, Deaton C, Ebrahim S, Fisher M, Germano G, Hobbs R, Hoes A, Karadeniz S, Mezzani A, Prescott E, Ryden L, Scherer M, Syvänne M, Scholte op Reimer WJ, Vrints C, Wood D, Zamorano JL, Zannad F, (EACPR) EAfCPaR, (CPG) ECfPG: European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J, 2012; 33: 1635-1701
33. Uehara G, Takeda H: Relative effects of telmisartan, candesartan and losartan on alleviating arterial stiffness in patients with hypertension complicated by diabetes mellitus: an evaluation using the cardio-ankle vascular index (CAVI). J Int Med Res, 2008; 36: 1094-1102
34. Kinouchi K, Ichihara A, Sakoda M, Kurauchi-Mito A, Itoh H: Safety and benefits of a tablet combining losartan and hydrochlorothiazide in Japanese diabetic patients with hypertension. Hypertens Res, 2009; 32: 1143-1147
35. Kinouchi K, Ichihara A, Sakoda M, Kurauchi-Mito A, Murohashi-Bokuda K, Itoh H: Effects of telmisartan on arterial stiffness assessed by the cardio-ankle vascular index in hypertensive patients. Kidney Blood Press Res, 2010; 33: 304-312
36. Sasaki H, Saiki A, Endo K, Ban N, Yamaguchi T, Kawana H, Nagayama D, Ohhira M, Oyama T, Miyashita Y, Shirai K: Protective effects of efonidipine, a T- and L-type calcium channel blocker, on renal function and arterial stiffness in type 2 diabetic patients with hypertension and nephropathy. J Atheroscler Thromb, 2009; 16: 568-575
37. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem, 1972; 18: 499-502
38. Bramwell J, Hill A: Velocity of the pulse wave in man. 1922; 93: 298-306
39. Nagayama D, Saiki A, Endo K, Yamaguchi T, Ban N, Kawana H, Ohira M, Oyama T, Miyashita Y, Shirai K: Improvement of cardio-ankle vascular index by glimepiride in type 2 diabetic patients. Int J Clin Pract, 2010; 64: 1796-1801
40. Iguchi A, Yamakage H, Tochiya M, Muranaka K, Sasaki Y, Kono S, Shimatsu A, Satoh-Asahara N: Effects of Weight Reduction Therapy on Obstructive Sleep Apnea Syndrome and Arterial Stiffness in Patients with Obesity and Metabolic Syndrome. J Atheroscler Thromb, 2013.
41. Liu H, Zhang X, Feng X, Li J, Hu M, Yambe T: Effects of metabolic syndrome on cardio-ankle vascular index in middle-aged and elderly Chinese. Metab Syndr Relat Disord, 2011; 9: 105-110
42. Soska V, Frantisova M, Dobsak P, Dusek L, Jarkovsky J, Novakova M, Shirai K, Fajkusova L, Freiberger T: Cardioankle vascular index in subjects with dyslipidaemia and other cardiovascular risk factors. J Atheroscler Thromb, 2013; 20: 443-451
43. Uurtuya S, Taniguchi N, Kotani K, Yamada T, Kawano M, Khurelbaatar N, Itoh K, Lkhagvasuren T: Comparative study of the cardio-ankle vascular index and anklebrachial index between young Japanese and Mongolian subjects. Hypertens Res, 2009; 32: 140-144
44. Nagayama D, Endo K, Ohira M, Yamaguchi T, Ban N, Kawana H, Nagumo A, Saiki A, Oyama T, Miyashita Y, Shirai K: Effects of body weight reduction on cardioankle vascular index (CAVI). Obesity Research & Clinical Practice, 2013; 7: E139-E145
45. Tomiyama H, Yamashina A: Central blood pressure--a possible latent factor affecting CAVI. J Atheroscler Thromb, 2011; 18: 720; author reply 721-722
46. Mayer L, Bacic-Vrca V, Sulentic P, Sisic I, Maric-Miholic V, Romovski S, Ljubic D: Correlation of Cardio-Ankle Vascular Index, Ten-Year Risk Assessment and Other Atherosclerosis Risk Factors. Collegium Antropologicum, 2011; 35: 167-172
47. Okura T, Watanabe S, Kurata M, Manabe S, Koresawa M, Irita J, Enomoto D, Miyoshi K, Fukuoka T, Higaki J: Relationship between cardio-ankle vascular index (CAVI) and carotid atherosclerosis in patients with essential hypertension. Hypertens Res, 2007; 30: 335-340
48. Wang H, Liu J, Zhao H, Fu X, Shang G, Zhou Y, Yu X, Zhao X, Wang G, Shi H: Arterial stiffness evaluation by cardio-ankle vascular index in hypertension and diabetes mellitus subjects. J Am Soc Hypertens, 2013
49. Takaki A, Ogawa H, Wakeyama T, Iwami T, Kimura M, Hadano Y, Matsuda S, Miyazaki Y, Matsuda T, Hiratsuka A, Matsuzaki M: Cardio-ankle vascular index is a new noninvasive parameter of arterial stiffness. Circ J, 2007; 71: 1710-1714
50. Higashiyama A, Wakabayashi I, Kubota Y, Adachi Y, Hayashibe A, Nishimura K, Sugiyama D, Kadota A, Imano H, Miyamatsu N, Miyamoto Y, Okamura T: Does highsensitivity C-reactive protein or low-density lipoprotein cholesterol show a stronger relationship with the cardioankle vascular index in healthy community dwellers ?: the KOBE study. J Atheroscler Thromb, 2012; 19: 1027-1034
51. Homma S, Kato K, Hayashi J, Yamamoto M: Negative Associations Between Arterial Stiffness Parameter Evaluated by Cardio-Ankle Vascular Index and Serum Low- Density Lipoprotein Cholesterol Concentration in Early- Stage Atherosclerosis. Angiology, 2014;
52. Miyamoto M, Kotani K, Okada K, Fujii Y, Konno K, Ishibashi S, Taniguchi N: The correlation of common carotid arterial diameter with atherosclerosis and diabetic retinopathy in patients with type 2 diabetes mellitus. Acta Diabetol, 2012; 49: 63-68
53. Wakabayashi I, Masuda H: Relationships between vascular indexes and atherosclerotic risk factors in patients with type 2 diabetes mellitus. Angiology, 2008; 59: 567-573
54. Wakabayashi I, Masuda H: [Effects of age on the relationship between cardio-ankle vascular index and atherosclerotic progression in patients with type 2 diabetes mellitus]. Nippon Ronen Igakkai Zasshi, 2006; 43: 217-221
55. Takaki A, Ogawa H, Wakeyama T, Iwami T, Kimura M, Hadano Y, Matsuda S, Miyazaki Y, Hiratsuka A, Matsuzaki M: Cardio-ankle vascular index is superior to brachial- ankle pulse wave velocity as an index of arterial stiffness. Hypertens Res, 2008; 31: 1347-1355
56. Oikawa O, Higuchi T, Yamazaki T, Yamamoto C, Fukuda N, Matsumoto K: Evaluation of serum fetuin-A relationships with biochemical parameters in patients on hemodialysis. Clin Exp Nephrol, 2007; 11: 304-308
57. Kadota K, Takamura N, Aoyagi K, Yamasaki H, Usa T, Nakazato M, Maeda T, Wada M, Nakashima K, Abe K, Takeshima F, Ozono Y: Availability of cardio-ankle vascular index (CAVI) as a screening tool for atherosclerosis. Circ J, 2008; 72: 304-308
58. Kuo HK, Chen CY, Liu HM, Yen CJ, Chang KJ, Chang CC, Yu YH, Lin LY, Hwang JJ: Metabolic risks, white matter hyperintensities, and arterial stiffness in high-functioning healthy adults. Int J Cardiol, 2010; 143: 184-191
59. Taguchi M, Ishigami M, Nishida M, Moriyama T, Yamashita S, Yamamura T: Remnant lipoprotein-cholesterol is a predictive biomarker for large artery atherosclerosis in apparently healthy women: usefulness as a parameter for annual health examinations. Annals of Clinical Biochemistry, 2011; 48: 332-337
60. Kondo A, Muranaka Y, Ohta I, Notsu K, Manabe M, Kotani K, Saito K, Maekawa M, Kanno T: Relationship between triglyceride concentrations and LDL size evaluated by malondialdehyde-modified LDL. Clin Chem, 2001; 47: 893-900
61. Satoh N, Shimatsu A, Kotani K, Himeno A, Majima T, Yamada K, Suganami T, Ogawa Y: Highly purified eicosapentaenoic acid reduces cardio-ankle vascular index in association with decreased serum amyloid A-LDL in metabolic syndrome. Hypertens Res, 2009; 32: 1004-1008
62. Stary HC, Chandler AB, Glagov S, Guyton JR, Insull W, Rosenfeld ME, Schaffer SA, Schwartz CJ, Wagner WD, Wissler RW: A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation, 1994; 89: 2462-2478
63. Takatori K, Matsumoto D, Okada Y, Nakamura J, Shomoto K: Effect of intensive rehabilitation on physical function and arterial function in community-dwelling chronic stroke survivors. Top Stroke Rehabil, 2012; 19: 377-383